WT1 AND MULTIPLE MYELOMA: A POTENTIAL IMMUNOTHERAPEUTIC APPROACH FOR HAEMATOLOGICAL MALIGNANCIES
Multiple myeloma (MM) is a haematological disease characterized by plasma cells malignancy and extramedullary and/or peripheral blood progression with significant patient morbidity, thus representing an urgent clinical need. Besides multiple affected sites, resistance to therapy is strongly limiting...
Hoofdauteur: | |
---|---|
Formaat: | Artikel |
Taal: | English |
Gepubliceerd in: |
Associazione Italiana Giovani Medici
2022-12-01
|
Reeks: | Euromediterranean Biomedical Journal |
Onderwerpen: | |
Online toegang: | http://www.embj.org/wp-content/uploads/2022/12/Dulcamare_38.pdf |